Neuroimaging Research Group
Mission
The Neuroimaging Research Group includes more than 20 clinical and research faculty and staff, postdoctoral fellows, and medical and graduate students who examine the brain’s structure and function, in health and disease, from genes to behavior, to develop and apply innovative techniques for imaging, analyzing, and monitoring the brain in neurologic and psychiatric disease.
We develop both precision medicine approaches for individual assessment and healing, and larger scale approaches to address neurologic and psychiatric disease. We research causes and treatments for brain disease and push the envelope of technology development in imaging modalities to guide the development and evaluation of novel therapies to create healthier futures for those suffering from brain tumors, neurodegenerative disorders (dementia, multiple sclerosis, Alzheimer’s, Parkinson’s, Huntington’s disease), neurological disorders (epilepsy, stroke, traumatic brain injury), psychiatric disorders (schizophrenia, depression), and hearing, speech, and voice disorders (deafness, tinnitus, laryngeal dystonia, stuttering).
Neuroimaging Research Directions
- Next Generation MRI Technology
- Non-Invasive Metabolic Imaging Biomarkers for Patients with Brain Tumors
- Multimodal MRI to Improve Neuromodulation Therapies
- Multimodal Neuroimaging in Progressive GBM Automated Post-Processing
- Workflow for Spectral Processing and Quality Control
Neuroimaging Research Labs
Neuroimaging Research Selected Publications
Members of the Neuroimaging Research Group